BIOMAT Database Logo BIOMAT Database Logo

[Prenatal brain damage in maternal, untreated phenylketonuria]. 1975

W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert

Several reports in literature exist about mentally retarded non-phenylketonuric offspring from untreated phenylketonuric mothers with normal intelligence. One additional case is added who was detected after screening of about 1600 pregnant women. Biochemical investigations of the mother identified her as "classical phenylketonuria". Column chromatographic analysis of amino acids in amniotic fluid revealed a very high pheylalanine level and the diminution of the other, especially essential amino acids. The estimated amino acids in fetal brain also revealed a very high phenylalanine level. Routine screening for phenylketonuria by means of the Guthrie's test is recommended for all pregnant women at the first visit of the counseling.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D005260 Female Females
D005315 Fetal Diseases Pathophysiological conditions of the FETUS in the UTERUS. Some fetal diseases may be treated with FETAL THERAPIES. Embryopathies,Disease, Fetal,Diseases, Fetal,Embryopathy,Fetal Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
[Fetal brain damage in maternal heterozygous phenylketonuria].
April 1970, Medizinische Klinik,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Foetal brain damage caused by maternal heterozygous phenylketonuria.
January 1979, Materia medica Polona. Polish journal of medicine and pharmacy,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Brain-damage syndrome in phenylketonuria.
October 1971, Perceptual and motor skills,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Risk of fetal damage in maternal phenylketonuria.
September 1973, The Journal of pediatrics,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Prenatal and postnatal developmental consequences of maternal phenylketonuria.
June 1966, Pediatrics,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Phenylpyruvate, fetal damage, and maternal phenylketonuria syndrome.
May 1993, Lancet (London, England),
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuria.
January 1990, Journal of inherited metabolic disease,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.
November 1983, The New England journal of medicine,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus.
July 1984, The New England journal of medicine,
W H Peters, and H Lubs, and G Machill, and A Knapp, and P Pietsch, and P Wiechert
Letter: Untreated phenylketonuria.
June 1974, Lancet (London, England),
Copied contents to your clipboard!